Target intelligence / Profile preview

Salmonella Typhimurium O-polysaccharide (O-PS) (O-PS)

Target
O-PS
Molecular classification
Polysaccharide, Bacterial surface antigen, Lipopolysaccharide component
01

Overview

Salmonella Typhimurium O-polysaccharide is the highly immunogenic, outermost component of the lipopolysaccharide (LPS) found on the cell surface of Salmonella enterica serovar Typhimurium. It consists of repeating oligosaccharide units—typically comprising D-galactose, L-rhamnose, and D-mannose with an abequose side chain—that determine the O-antigenic specificity (serogroup B) of the bacterium (Micoli et al., 2018). Biologically, this polysaccharide acts as a protective shield against the host's innate immune system, specifically preventing the membrane attack complex of the complement system from reaching the bacterial outer membrane (MacLennan et al., 2014). It also serves as a receptor for various bacteriophages and plays a role in biofilm formation and environmental survival. In clinical medicine, the O-polysaccharide is a major target for vaccine development, particularly glycoconjugate vaccines where the polysaccharide is chemically linked to a carrier protein to enhance T-cell dependent immune responses (Baliban et al., 2017). Therapeutic strategies focusing on this target aim to elicit bactericidal antibodies that promote opsonophagocytosis and neutralize the pathogen during infection (Rondini et al., 2013). Challenges in targeting this molecule include its high structural diversity across different serovars and the necessity of removing the toxic Lipid A component during the manufacturing of polysaccharide-based therapeutics (Micoli et al., 2018).

Other names
Salmonella Typhimurium O-antigenSalmonella enterica serovar Typhimurium O-antigenGroup B O-antigenLPS O-side chain
02

Mechanism of action

Induction of opsonophagocytic and bactericidal antibodies

03

Biological functions

Immune responseImmune evasionStructural integrityPathogenicityPhage receptor
04

Disease associations

InfectionGastroenteritisSalmonellosisSepsis
05

Safety considerations

Endotoxin contaminationSerotype-specific protectionT-cell independent immunogenicity in isolation
06

Interacting drugs

CVD 1921

4 more in the full profile.

07

Biomarkers

Anti-O:4,5,12 antibody titerSerum bactericidal activity (SBA)

Beyond the preview

Go deeper on Salmonella Typhimurium O-polysaccharide (O-PS) (O-PS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Typhimurium O-polysaccharide (O-PS) (O-PS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call